Simultaneous determination of pioglitazone and glimepiride in bulk drug and pharmaceutical dosage form by RP-HPLC method

A. Karthik, G. Subramanian, C. Mallikarjuna Rao, Krishnamurthy Bhat, A. Ranjithkumar, P. Musmade, M. Surulivelrajan, K. Karthikeyan, N. Udupa

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

A simple, fast, and precise reverse phase, isocratic HPLC method was developed for the separation and quantification of pioglitazone and glimepiride in bulk drug and pharmaceutical dosage form. The quantification was carried out using Inertsil ODS (250 × 4.6 mm, 5μ) column and mobile phase comprised of acetonitrile and ammonium acetate (pH 4.5; 20mM) in proportion of 60:40 (v/v). The flow rate was 1.0 ml/min and the effluent was monitored at 230 nm. The retention time of pioglitazone and glimepiride were 7.0±0.1 and 10.2±0.1 min respectively. The method was validated in terms of linearity, precision, accuracy, and specificity, limit of detection and limit of quantitation. Linearity of pioglitazone and glimepiride were in the range of 2.0 to 200.0μg/ml and 0.5-50μg/ml respectively. The percentage recoveries of both the drugs were 99.85% and 102.06% for pioglitazone and glimepiride respectively from the tablet formulation. The proposed method is suitable for simultaneous determination of pioglitazone and glimepiride in pharmaceutical dosage form and bulk drug.
Original languageEnglish
Pages (from-to)421-425
Number of pages5
JournalPakistan Journal of Pharmaceutical Sciences
Volume21
Issue number4
Publication statusPublished - 2008

    Fingerprint

Cite this